348 related articles for article (PubMed ID: 28637186)
1. CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.
Pan H; Bilinovich SM; Kaur P; Riehn R; Wang H; Williams DC
Nucleic Acids Res; 2017 Sep; 45(15):9164-9177. PubMed ID: 28637186
[TBL] [Abstract][Full Text] [Related]
2. Densely methylated DNA traps Methyl-CpG-binding domain protein 2 but permits free diffusion by Methyl-CpG-binding domain protein 3.
Leighton GO; Irvin EM; Kaur P; Liu M; You C; Bhattaram D; Piehler J; Riehn R; Wang H; Pan H; Williams DC
J Biol Chem; 2022 Oct; 298(10):102428. PubMed ID: 36037972
[TBL] [Abstract][Full Text] [Related]
3. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
[TBL] [Abstract][Full Text] [Related]
4. An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex.
Desai MA; Webb HD; Sinanan LM; Scarsdale JN; Walavalkar NM; Ginder GD; Williams DC
Nucleic Acids Res; 2015 Mar; 43(6):3100-13. PubMed ID: 25753662
[TBL] [Abstract][Full Text] [Related]
5. Tagging methyl-CpG-binding domain proteins reveals different spatiotemporal expression and supports distinct functions.
Wood KH; Johnson BS; Welsh SA; Lee JY; Cui Y; Krizman E; Brodkin ES; Blendy JA; Robinson MB; Bartolomei MS; Zhou Z
Epigenomics; 2016 Apr; 8(4):455-73. PubMed ID: 27066839
[TBL] [Abstract][Full Text] [Related]
6. Structural analyses reveal that MBD3 is a methylated CG binder.
Liu K; Lei M; Wu Z; Gan B; Cheng H; Li Y; Min J
FEBS J; 2019 Aug; 286(16):3240-3254. PubMed ID: 30980593
[TBL] [Abstract][Full Text] [Related]
7. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
Jiang CL; Jin SG; Pfeifer GP
J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.
Zhang Y; Ng HH; Erdjument-Bromage H; Tempst P; Bird A; Reinberg D
Genes Dev; 1999 Aug; 13(15):1924-35. PubMed ID: 10444591
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the complex between MBD2 and the histone deacetylase core of NuRD reveals key interactions critical for gene silencing.
Leighton GO; Shang S; Hageman S; Ginder GD; Williams DC
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2307287120. PubMed ID: 37552759
[TBL] [Abstract][Full Text] [Related]
10. Probing the dynamic distribution of bound states for methylcytosine-binding domains on DNA.
Cramer JM; Scarsdale JN; Walavalkar NM; Buchwald WA; Ginder GD; Williams DC
J Biol Chem; 2014 Jan; 289(3):1294-302. PubMed ID: 24307175
[TBL] [Abstract][Full Text] [Related]
11. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes.
Feng Q; Zhang Y
Genes Dev; 2001 Apr; 15(7):827-32. PubMed ID: 11297506
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation directs genomic localization of Mbd2 and Mbd3 in embryonic stem cells.
Hainer SJ; McCannell KN; Yu J; Ee LS; Zhu LJ; Rando OJ; Fazzio TG
Elife; 2016 Nov; 5():. PubMed ID: 27849519
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the behavior and function of MBD3 in DNA methylation homeostasis by single-molecule spectroscopy and microscopy.
Cui Y; Irudayaraj J
Nucleic Acids Res; 2015 Mar; 43(6):3046-55. PubMed ID: 25753672
[TBL] [Abstract][Full Text] [Related]
14. Methyl-CpG-binding domain proteins: readers of the epigenome.
Du Q; Luu PL; Stirzaker C; Clark SJ
Epigenomics; 2015; 7(6):1051-73. PubMed ID: 25927341
[TBL] [Abstract][Full Text] [Related]
15. Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences.
Günther K; Rust M; Leers J; Boettger T; Scharfe M; Jarek M; Bartkuhn M; Renkawitz R
Nucleic Acids Res; 2013 Mar; 41(5):3010-21. PubMed ID: 23361464
[TBL] [Abstract][Full Text] [Related]
16. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.
Le Guezennec X; Vermeulen M; Brinkman AB; Hoeijmakers WA; Cohen A; Lasonder E; Stunnenberg HG
Mol Cell Biol; 2006 Feb; 26(3):843-51. PubMed ID: 16428440
[TBL] [Abstract][Full Text] [Related]
17. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions.
Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R
Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253
[TBL] [Abstract][Full Text] [Related]
18. MBD2 and multiple domains of CHD4 are required for transcriptional repression by Mi-2/NuRD complexes.
Ramírez J; Dege C; Kutateladze TG; Hagman J
Mol Cell Biol; 2012 Dec; 32(24):5078-88. PubMed ID: 23071088
[TBL] [Abstract][Full Text] [Related]
19. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
[TBL] [Abstract][Full Text] [Related]
20. Methylation-dependent and -independent genomic targeting principles of the MBD protein family.
Baubec T; Ivánek R; Lienert F; Schübeler D
Cell; 2013 Apr; 153(2):480-92. PubMed ID: 23582333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
